Ascelia Pharma (Sweden) Price History
ACE Stock | SEK 3.18 0.01 0.31% |
If you're considering investing in Ascelia Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ascelia Pharma stands at 3.18, as last reported on the 18th of January 2025, with the highest price reaching 3.22 and the lowest price hitting 3.10 during the day. Ascelia Pharma appears to be very risky, given 3 months investment horizon. Ascelia Pharma AB secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of standard deviation over the last 3 months. By analyzing Ascelia Pharma's technical indicators, you can evaluate if the expected return of 0.7% is justified by implied risk. Please makes use of Ascelia Pharma's mean deviation of 3.13, and Risk Adjusted Performance of 0.1292 to double-check if our risk estimates are consistent with your expectations.
Ascelia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ascelia |
Sharpe Ratio = 0.1594
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ACE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.39 actual daily | 39 61% of assets are more volatile |
Expected Return
0.7 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Ascelia Pharma is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascelia Pharma by adding it to a well-diversified portfolio.
Ascelia Pharma Stock Price History Chart
There are several ways to analyze Ascelia Stock price data. The simplest method is using a basic Ascelia candlestick price chart, which shows Ascelia Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 12, 2024 | 3.46 |
Lowest Price | October 25, 2024 | 2.08 |
Ascelia Pharma January 18, 2025 Stock Price Synopsis
Various analyses of Ascelia Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ascelia Stock. It can be used to describe the percentage change in the price of Ascelia Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ascelia Stock.Ascelia Pharma Price Rate Of Daily Change | 1.00 | |
Ascelia Pharma Price Daily Balance Of Power | (0.08) | |
Ascelia Pharma Price Action Indicator | 0.02 |
Ascelia Pharma January 18, 2025 Stock Price Analysis
Ascelia Stock Price History Data
The price series of Ascelia Pharma for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 1.38 with a coefficient of variation of 15.03. The prices are distributed with arithmetic mean of 2.7. The median price for the last 90 days is 2.76.Open | High | Low | Close | Volume | ||
01/18/2025 | 3.19 | 3.22 | 3.10 | 3.18 | ||
01/17/2025 | 3.19 | 3.22 | 3.10 | 3.18 | 389,980 | |
01/16/2025 | 3.14 | 3.25 | 3.08 | 3.19 | 493,217 | |
01/15/2025 | 2.83 | 3.20 | 2.81 | 3.14 | 1,146,172 | |
01/14/2025 | 2.92 | 2.97 | 2.81 | 2.83 | 593,029 | |
01/13/2025 | 2.99 | 3.00 | 2.85 | 2.92 | 1,011,307 | |
01/10/2025 | 2.73 | 3.04 | 2.67 | 2.99 | 1,538,767 | |
01/09/2025 | 2.84 | 2.87 | 2.70 | 2.71 | 1,282,393 | |
01/08/2025 | 2.82 | 2.94 | 2.75 | 2.82 | 1,217,861 | |
01/07/2025 | 3.00 | 3.00 | 2.83 | 2.85 | 1,654,054 | |
01/03/2025 | 3.06 | 3.06 | 2.96 | 2.96 | 517,699 | |
01/02/2025 | 2.95 | 3.08 | 2.91 | 3.07 | 612,505 | |
12/30/2024 | 3.01 | 3.04 | 2.80 | 2.92 | 1,825,022 | |
12/27/2024 | 3.09 | 3.11 | 2.96 | 3.03 | 508,747 | |
12/23/2024 | 3.04 | 3.08 | 2.92 | 3.06 | 875,290 | |
12/20/2024 | 2.97 | 3.18 | 2.95 | 3.00 | 1,185,341 | |
12/19/2024 | 3.06 | 3.06 | 2.93 | 3.01 | 832,746 | |
12/18/2024 | 3.20 | 3.21 | 2.99 | 3.10 | 1,391,176 | |
12/17/2024 | 3.24 | 3.33 | 3.14 | 3.18 | 871,961 | |
12/16/2024 | 3.45 | 3.53 | 3.22 | 3.23 | 1,047,740 | |
12/13/2024 | 3.46 | 3.64 | 3.37 | 3.39 | 2,195,806 | |
12/12/2024 | 3.33 | 3.49 | 3.30 | 3.46 | 1,205,675 | |
12/11/2024 | 3.20 | 3.33 | 3.11 | 3.33 | 701,198 | |
12/10/2024 | 3.24 | 3.45 | 3.13 | 3.16 | 2,579,110 | |
12/09/2024 | 3.01 | 3.25 | 3.01 | 3.20 | 1,127,820 | |
12/06/2024 | 3.25 | 3.25 | 2.96 | 2.97 | 994,925 | |
12/05/2024 | 2.95 | 3.25 | 2.86 | 3.17 | 1,263,549 | |
12/04/2024 | 2.88 | 2.99 | 2.70 | 2.97 | 1,146,639 | |
12/03/2024 | 2.95 | 2.99 | 2.82 | 2.86 | 419,338 | |
12/02/2024 | 2.90 | 2.96 | 2.82 | 2.90 | 624,753 | |
11/29/2024 | 2.90 | 2.93 | 2.79 | 2.90 | 477,398 | |
11/28/2024 | 3.01 | 3.03 | 2.86 | 2.90 | 692,636 | |
11/27/2024 | 2.95 | 3.04 | 2.95 | 3.01 | 883,008 | |
11/26/2024 | 2.78 | 2.98 | 2.78 | 2.94 | 875,810 | |
11/25/2024 | 2.75 | 2.85 | 2.57 | 2.75 | 599,652 | |
11/22/2024 | 2.65 | 2.73 | 2.55 | 2.71 | 542,708 | |
11/21/2024 | 2.67 | 2.77 | 2.55 | 2.62 | 405,609 | |
11/20/2024 | 2.73 | 2.78 | 2.60 | 2.67 | 513,050 | |
11/19/2024 | 2.80 | 2.92 | 2.59 | 2.72 | 912,109 | |
11/18/2024 | 2.65 | 2.80 | 2.65 | 2.76 | 793,522 | |
11/15/2024 | 2.60 | 2.68 | 2.56 | 2.63 | 470,860 | |
11/14/2024 | 2.62 | 2.73 | 2.54 | 2.55 | 693,447 | |
11/13/2024 | 2.57 | 2.68 | 2.47 | 2.59 | 676,895 | |
11/12/2024 | 2.65 | 2.81 | 2.50 | 2.55 | 962,859 | |
11/11/2024 | 2.68 | 2.80 | 2.57 | 2.65 | 1,007,451 | |
11/08/2024 | 2.37 | 2.84 | 2.37 | 2.71 | 3,238,200 | |
11/07/2024 | 2.30 | 2.45 | 2.17 | 2.36 | 2,659,403 | |
11/06/2024 | 2.15 | 2.17 | 2.08 | 2.09 | 400,433 | |
11/05/2024 | 2.10 | 2.17 | 2.05 | 2.14 | 527,711 | |
11/04/2024 | 2.16 | 2.17 | 2.06 | 2.11 | 685,582 | |
11/01/2024 | 2.22 | 2.22 | 2.15 | 2.17 | 225,317 | |
10/31/2024 | 2.19 | 2.23 | 2.15 | 2.19 | 537,918 | |
10/30/2024 | 2.18 | 2.23 | 2.15 | 2.19 | 433,823 | |
10/29/2024 | 2.17 | 2.26 | 2.15 | 2.18 | 907,205 | |
10/28/2024 | 2.09 | 2.20 | 2.05 | 2.16 | 1,308,028 | |
10/25/2024 | 2.09 | 2.12 | 2.06 | 2.08 | 667,966 | |
10/24/2024 | 2.12 | 2.17 | 2.08 | 2.09 | 793,969 | |
10/23/2024 | 2.17 | 2.17 | 2.11 | 2.15 | 391,558 | |
10/22/2024 | 2.21 | 2.22 | 2.13 | 2.15 | 457,543 | |
10/21/2024 | 2.21 | 2.25 | 2.15 | 2.21 | 437,805 | |
10/18/2024 | 2.17 | 2.24 | 2.15 | 2.21 | 528,685 |
About Ascelia Pharma Stock history
Ascelia Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascelia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascelia Pharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascelia Pharma stock prices may prove useful in developing a viable investing in Ascelia Pharma
Ascelia Pharma AB operates as an oncology focused specialty pharmaceutical company that develops medicines to enhance the life expectancy for people living with cancer and cancer-related diseases in Sweden and Denmark. The company was founded in 2000 and is headquartered in Malm, Sweden. Ascelia Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 4 people.
Ascelia Pharma Stock Technical Analysis
Ascelia Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
All Next | Launch Module |
Ascelia Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascelia Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascelia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascelia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1292 | |||
Jensen Alpha | 0.6189 | |||
Total Risk Alpha | 0.4999 | |||
Sortino Ratio | 0.2233 | |||
Treynor Ratio | (0.59) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.